Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
about
Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literatureA structured review of health utility measures and elicitation in advanced/metastatic breast cancerCost-utility analyses of drug therapies in breast cancer: a systematic review.Economic analyses of breast cancer control in low- and middle-income countries: a systematic review.
P2860
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
@en
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
@nl
type
label
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
@en
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
@nl
prefLabel
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
@en
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
@nl
P2860
P1476
Cost-utility analysis of adjuvant therapies for breast cancer in Iran
@en
P2093
Aliasghar Ahmad Kiadaliri
P2860
P304
P356
10.1017/S0266462312000049
P577
2012-04-01T00:00:00Z